Table 3.

Physical activity at T0, T1, T3, and T6 in biologic therapy (BT) omalizumab and BT mepolizumab groups.

Parameters	BT omalizumab				BT mepolizumab
Experimental times	T0	T1	T3	T6	T0	T1	T3	T6
SPD, n	3,818.1 ± 454.84	4,525 ± 496.5	5,106 ± 616.7	6,508.53 ± 930.9	3,794.13 ± 401.3	4,352.13 ± 494.6	5,379.6 ± 681.7	6,581.66 ± 778.8
Total EE, kcal/day	1,325.2 ± 161.4	1,604± 177	1,807.4 ± 219.5	2,121 ± 394.9	1,310.9 ± 162.9	1,583 ± 197	1,831 ± 249.6	2,132.6 ± 487.4

SPD, number of steps per day; EE, estimated energy expenditure. Data are presented as the mean ± SD.